195 related articles for article (PubMed ID: 25876571)
21. Helicobacter pylori and mucosa-associated lymphoid tissue: what's new.
Kuo SH; Cheng AL
Hematology Am Soc Hematol Educ Program; 2013; 2013():109-17. PubMed ID: 24319171
[TBL] [Abstract][Full Text] [Related]
22. Helicobacter pylori eradication for low-grade gastric mucosa-associated lymphoid tissue lymphoma is more successful in inducing remission in distal compared to proximal disease.
Kim JS; Chung SJ; Choi YS; Cheon JH; Kim CW; Kim SG; Jung HC; Song IS
Br J Cancer; 2007 May; 96(9):1324-8. PubMed ID: 17406363
[TBL] [Abstract][Full Text] [Related]
23. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment.
Nakamura S; Matsumoto T; Suekane H; Nakamura S; Matsumoto H; Esaki M; Yao T; Iida M
Cancer; 2005 Aug; 104(3):532-40. PubMed ID: 15937928
[TBL] [Abstract][Full Text] [Related]
24. Gastric mucosal-associated lymphoid tissue lymphoma.
Fischbach W
Gastroenterol Clin North Am; 2013 Jun; 42(2):371-80. PubMed ID: 23639646
[TBL] [Abstract][Full Text] [Related]
25. Review article: common misconceptions in the management of Helicobacter pylori-associated gastric MALT-lymphoma.
Gisbert JP; Calvet X
Aliment Pharmacol Ther; 2011 Nov; 34(9):1047-62. PubMed ID: 21919927
[TBL] [Abstract][Full Text] [Related]
26. Treatment for gastric mucosa-associated lymphoid tissue (MALT) lymphoma.
Maeda T; Niitsu N
Intern Med; 2006; 45(6):353-4. PubMed ID: 16617183
[No Abstract] [Full Text] [Related]
27. Exclusive moderate-dose radiotherapy in gastric marginal zone B-cell MALT lymphoma: Results of a prospective study with a long term follow-up.
Ruskoné-Fourmestraux A; Matysiak-Budnik T; Fabiani B; Cervera P; Brixi H; Le Malicot K; Nion-Larmurier I; Fléjou JF; Hennequin C; Quéro L;
Radiother Oncol; 2015 Oct; 117(1):178-82. PubMed ID: 26395311
[TBL] [Abstract][Full Text] [Related]
28. Recurrent gastric perforation as a late complication of radiotherapy for mucosa-associated lymphoid tissue lymphoma of the stomach.
Otsuka T; Noda T; Yokoo M; Ibaraki K
Intern Med; 2008; 47(15):1407-9. PubMed ID: 18670146
[TBL] [Abstract][Full Text] [Related]
29. Regression of primary gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma after eradication of Helicobacter pylori.
Falcó Jover G; Martínez Egea A; Sánchez Cuenca J; Onrubia Pintado J; García Lafuente N; Ruiz Gómez F; Coronas Planas M
Rev Esp Enferm Dig; 1999 Aug; 91(8):541-8. PubMed ID: 10491486
[TBL] [Abstract][Full Text] [Related]
30. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
[TBL] [Abstract][Full Text] [Related]
31. Increased plasmacytic differentiation in gastric mucosa-associated lymphoid tissue lymphomas: Helicobacter pylori eradication response and IgG4+ plasma cell association.
Park S; Ahn S; Hong M; Ko YH
Hum Pathol; 2017 Jan; 59():113-119. PubMed ID: 27697589
[TBL] [Abstract][Full Text] [Related]
32. Long-term follow-up of disappearance of gastric mucosa-associated lymphoid tissue after anti-Helicobacter pylori therapy.
Tursi A; Cammarota G; Papa A; Cuoco L; Fedeli G; Gasbarrini G
Am J Gastroenterol; 1997 Oct; 92(10):1849-52. PubMed ID: 9382050
[TBL] [Abstract][Full Text] [Related]
33. Gastric lymphoma of mucosa-associated lymphoid tissue and Helicobacter pylori.
Wotherspoon AC
Annu Rev Med; 1998; 49():289-99. PubMed ID: 9509264
[TBL] [Abstract][Full Text] [Related]
34. The value of EUS in predicting the response of gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication.
El-Zahabi LM; Jamali FR; El-Hajj II; Naja M; Salem Z; Shamseddine A; El-Saghir NS; Zaatari G; Geara F; Soweid AM
Gastrointest Endosc; 2007 Jan; 65(1):89-96. PubMed ID: 17185085
[TBL] [Abstract][Full Text] [Related]
35. Radiation therapy for localized low-grade non-Hodgkin's lymphomas.
Tsang RW; Gospodarowicz MK
Hematol Oncol; 2005 Mar; 23(1):10-7. PubMed ID: 16158458
[TBL] [Abstract][Full Text] [Related]
36. Helicobacter pylori-negative / API2-MALT1 translocation-negative low-grade MALT lymphoma.
Nozaki K; Nomura S; Shimizu N; Hiki N; Yoshizawa N; Aikou S; Kubota K; Yamaguchi H; Kurosaka H; Shinozaki A; Mafune K; Fukayama M; Kaminishi M
Gastric Cancer; 2006; 9(3):229-34. PubMed ID: 16952043
[TBL] [Abstract][Full Text] [Related]
37. Gastric lymphomas: genetics and resistance to H. pylori eradication.
Isaacson PG; Du MQ
Verh Dtsch Ges Pathol; 2003; 87():116-22. PubMed ID: 16888902
[TBL] [Abstract][Full Text] [Related]
38. Treatment Strategy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.
Nakamura S; Matsumoto T
Gastroenterol Clin North Am; 2015 Sep; 44(3):649-60. PubMed ID: 26314674
[TBL] [Abstract][Full Text] [Related]
39. [Prognostic impact of Helicobacter pylori infection and eradication therapy in gastric mucosa-associated lymphoid tissue lymphoma].
Park SH; Chi HS; Park SJ; Jang S; Park CJ; Huh JR
Korean J Lab Med; 2010 Dec; 30(6):547-53. PubMed ID: 21157137
[TBL] [Abstract][Full Text] [Related]
40. Consecutive regression of concurrent laryngeal and gastric MALT lymphoma after anti-Helicobacter pylori therapy.
Caletti G; Togliani T; Fusaroli P; Sabattini E; Khodadadian E; Gamberi B; Gobbi M; Pileri S
Gastroenterology; 2003 Feb; 124(2):537-43. PubMed ID: 12557157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]